Literature DB >> 29502917

Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine.

Didem Demirbas1, William J Brucker1, Gerard T Berry2.   

Abstract

The liver is one of the most essential organs in metabolism and is responsible for metabolizing a wide variety of molecules from amino acids to sugars. Although it is responsible for many essential metabolic processes, it is one of the most severely affected by metabolic disease because, in many cases, it is the first to be exposed to the toxic intermediates. The metabolism of galactose, fructose, and tyrosine involve the liver and although there are systemic findings in metabolic disease involved with these substrates, severe hepatopathy is a common presenting aspect of galactosemia, hereditary fructose intolerance, and tyrosinemia type I.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fructose intolerance; Galactosemia; Hepatopathy; Inborn errors of metabolism; Liver; Liver disease; Nitisinone; Tyrosinemia

Mesh:

Substances:

Year:  2018        PMID: 29502917     DOI: 10.1016/j.pcl.2017.11.008

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  6 in total

Review 1.  Inborn errors of metabolism in the differential diagnosis of fatty liver disease.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

Review 2.  Recent developments in diagnostics and treatment of neonatal cholestasis.

Authors:  Amy G Feldman; Ronald J Sokol
Journal:  Semin Pediatr Surg       Date:  2020-07-23       Impact factor: 2.754

3.  Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'.

Authors:  Rebeca Saborido-Fiaño; Nazareth Martinón-Torres; Vanesa Crujeiras-Martinez; Maria Luz Couce; Rosaura Leis
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

4.  Glycine-Serine-Threonine Metabolic Axis Delays Intervertebral Disc Degeneration through Antioxidant Effects: An Imaging and Metabonomics Study.

Authors:  Xiaolin Wu; Chang Liu; Shuai Yang; Nana Shen; Yan Wang; Youfu Zhu; Zhaoyang Guo; Shang-You Yang; Dongming Xing; Houxi Li; Zhu Guo; Bohua Chen; Hongfei Xiang
Journal:  Oxid Med Cell Longev       Date:  2021-08-25       Impact factor: 6.543

Review 5.  Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.

Authors:  Pankaj Puri; Radha K Dhiman; Sunil Taneja; Puneeta Tandon; Manuela Merli; Anil C Anand; Anil Arora; Subrat K Acharya; Jaya Benjamin; Yogesh K Chawla; Sunil Dadhich; Ajay Duseja; C E Eapan; Amit Goel; Naveen Kalra; Dharmesh Kapoor; Ashish Kumar; Kaushal Madan; Aabha Nagral; Gaurav Pandey; Padaki N Rao; Sanjiv Saigal; Neeraj Saraf; Vivek A Saraswat; Anoop Saraya; Shiv K Sarin; Praveen Sharma; Akash Shukla; Sandeep S Sidhu; Namrata Singh; Shivaram P Singh; Anshu Srivastava; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2020-10-01

Review 6.  Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts.

Authors:  Ralf Weiskirchen; Sabine Weiskirchen; Frank Tacke
Journal:  F1000Res       Date:  2018-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.